Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$143.65
+0.7%
$150.90
$130.27
$161.41
$1.09B0.8528,857 shs39,458 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.03
+1.6%
$4.90
$2.13
$7.37
$328.11M1.1759,288 shs27,982 shs
SXS
3798 (SXS.V)
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
-1.90%+0.76%-6.83%-5.41%-5.69%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-2.17%+3.13%+0.61%+1.02%+6.22%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.288 of 5 stars
3.55.00.00.01.80.00.6
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
0.00
N/A$191.9533.62% Upside
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
3.00
Buy$8.0059.05% Upside
SXS
3798 (SXS.V)
N/AN/AN/AN/A

Current Analyst Ratings

Latest SXS, FBT, RSW, and SOPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
3/6/2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$8.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$62.37M5.26N/AN/A$3.16 per share1.59
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/A16.52N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$78.98M-$1.22N/AN/AN/A-126.63%-47.40%-36.43%5/7/2024 (Confirmed)
SXS
3798 (SXS.V)
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest SXS, FBT, RSW, and SOPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.28N/A+$0.28N/AN/AN/A  
3/5/202412/31/2023
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.25-$0.37-$0.12-$0.37$16.78 million$17.05 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/A
4.16
3.97
SXS
3798 (SXS.V)
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
SXS
3798 (SXS.V)
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A7.60 millionN/ANot Optionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
43065.23 million62.05 millionNot Optionable
SXS
3798 (SXS.V)
147,000N/AN/ANot Optionable

SXS, FBT, RSW, and SOPH Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

First Trust NYSE Arca Biotechnology Index Fund logo

First Trust NYSE Arca Biotechnology Index Fund

NYSEARCA:FBT
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
SOPHiA GENETICS logo

SOPHiA GENETICS

NASDAQ:SOPH
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

3798 (SXS.V)

CVE:SXS
Solimar Energy Limited (Solimar) is an Australia-based oil and gas production and exploration company. The Company has a multi-project asset base focused in the oil prolific San Joaquin Basin, onshore California. The Company's assets are mainly in oil prone trends adjacent giant fields and target both conventional (sandstone) and unconventional (fractured oil shale) reservoirs. Solimar is engaged in conversion of an oil and gas resource potential within its acreage to reserves. The Company operates most of its assets, holding high equity positions. This includes a control position in the Kreyenhagen oil field with significant volumes of oil intersected by numerous wells within the Company's control acreage. The Company's projects include Kreyenhagen, Bayswater, Jacalitos, SELH, Paloma and Tejon Footwall. The Company's subsidiaries include Solimar Australia Energy Pty Ltd and Livingstone Energy Inc.